Accueil • Life Sciences And Research Solutions • Our Innovation Partners Our Innovation Partners Access the Latest Research Advances Technologies partnered with a fully automated workflow yield visionary outcomes. Download our latest brochure Now! Leica Biosystems collaborates with diverse, cutting-edge technologies to co-develop flexible, open platforms that automate your tissue-based research workflows. Our Open Innovation (OI) partnerships enable easy integration across technologies, supporting fluorescent and chromogenic protocols. Our OI partnership collaborations bring creative solutions helping to answer your most pressing research questions. About Our Partnerships Innovation Meets Automation Leica Biosystems partners with a range of Open Innovation (OI) partners. As a result, you have many flexible solutions for your research. Most protocols and protocol templates developed in conjunction with our OI partners are available on BOND RX and BOND RXm staining systems so you can access the latest research advances quickly. Contact an Expert Image For Research Use Only. Not for use in diagnostic procedures. Our Global Partners NanoString High Plex, Spatial Profiling of Proteins and RNA from FFPE Combining standard immunofluorescence techniques with digital optical barcoding technology, the GeoMx® Digital Spatial Profiler enables high plex, spatially-resolved profiling of protein and RNA. The GeoMx Assays allow for imaging and profiling from a single FFPE or fresh frozen tissue section. Quantify with spatial context 150+ proteins and up to the whole transcriptome Focus on rare cells or compartment-specific regions of interest in tissue Preserve precious samples with non-destructive processing Learn More Image ACD A Fully Integrated RNA ISH Solution Complete up to 30 slides in a single 11-hour run for single plex (and a 14-hour run for duplex) with high-throughput staining. This solution is: Highly specific – Amplifies signals using double z probe strategy and simultaneous background suppression strategy to ensure target-specific binding. Sensitive & Quantitative – Detects single RNA molecules at single cell resolution. Morphological – Provides cell specific expression in information intact tissue architecture. Universal – Use for virtually any gene, species or tissue. Learn More Image Ultivue Single Step Multiplexing, Fully Automated Create up to 30, five color multiplex slides in under 6 hours hours on BOND RX whilst preserving tissue morphology and integrity. Spend less time perfecting difficult manual techniques and more time focusing on your next research breakthrough. Survey and analyse cell phenotypes with spatial context within the tumor microenvironment though high performance tissue-based biomarker multiplex assays Multiplex on a single slide, using a single antibody cocktail and incubation step, powered by DNA barcoded antibodies with unique, complementary, fluorescent DNA barcodes Preserve sample integrity for additional analyses without damaging tissue or cross talk Image and analyse with Aperio VERSA and Aperio Cellular IF Algorithm Image On-Demand Presentations Our featured webinars showcase the power of Leica Biosystems automated solutions and partner technologies. Watch now to envision your research outcomes. Image NanoString Characterization of the Pancreatic Tumor Microenvironment using Novel Quantitative Multiplex DSP Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease associated with poor outcomes. So far, the factors and pathways underlying patient survival in PDAC are unknown. View Webinar Image ACD Introducing New RNA-Protein Co-Detection Assays Learn more about ACD’s new Co-detection Assays, which will allow researchers to simultaneously examine cell-type-specific gene expression and identify cellular sources of secreted proteins. View Webinar Image Ultivue Strategies for Spatial Multi-omics: Co-detection of protein and RNA biomarkers on a single FFPE tissue section powered by InSituPlex® Technology Understanding the complexities of a particular tumor microenvironment can vastly improve the accuracy of immuno-oncology clinical prognosis and accelerate the discovery of immunotherapy targets towards patient-focused personalized medicine. View Article Cutting Edge Tech: Success Stories NanoString Implementation of Fully Automated BOND RX Protocol for NanoString's GeoMx® Assay ACD Automated, Multiplexed Co-detection of RNA and Protein: Explore Partnering With Us Contact us
